Profile: Guided Therapeutics Inc (GTHP.OB)

GTHP.OB on OTC BB

0.22USD
19 Dec 2014
Price Change (% chg)

$-0.00 (-2.22%)
Prev Close
$0.22
Open
$0.22
Day's High
$0.22
Day's Low
$0.22
Volume
188,486
Avg. Vol
219,299
52-wk High
$0.63
52-wk Low
$0.20

Search Stocks

Guided Therapeutics, Inc., incorporated on October 27, 1992, is a medical technology company focused on developing medical devices. The Company’s primary focus is the development of its LuViva non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, especially esophageal. Its technology, including products in research and development, primarily relate to biophotonics technology for the non-invasive detection of cancers. LuViva is a non-invasive cervical cancer detection product, based on the Company's biophotonic technology. The device is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix.

The Company's product, in addition to detecting the structural changes attributed to cervical cancer, is also designed to detect the biochemical changes that precede the development of visual lesions. The product is expected to incorporate a single-use, disposable calibration and alignment component.

The Company competes with Qiagen, MediSpectra, Inc., Merck & Co., Inc., and GlaxoSmithKline PLC.

Company Address

Guided Therapeutics Inc

5835 Peachtree Cors E Ste D
NORCROSS   GA   30092-3413
P: +1770.2428723
F: +1302.6555049

Search Stocks